ArticleNature communications2021
BRD4-mediated repression of p53 is a target for combination therapy in AML.
Anne-Louise Latif et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.
50 papers cite it
this papercites it
ArticleNature communications2021
Anne-Louise Latif et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.